Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
XORTX Therapeutics Inc. (XRTX) had Return on Tangible Equity of -31.09% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.59M |
|
-- |
|
-- |
|
$0.69M |
|
$-0.69M |
|
$0.10M |
|
$-0.59M |
|
$-0.59M |
|
$-0.59M |
|
$-0.59M |
|
$-0.59M |
|
$-0.59M |
|
$-0.69M |
|
$-0.66M |
|
0.95M |
|
0.95M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$1.26M |
|
$0.04M |
|
$1.42M |
|
$2.68M |
|
$0.60M |
|
-- |
|
-- |
|
$0.60M |
|
$2.08M |
|
$1.90M |
|
$2.08M |
|
1.39M |
|
| Cash Flow Statement Financials | |
$-2.77M |
|
$-0.29M |
|
$1.43M |
|
$2.47M |
|
$0.86M |
|
$-1.61M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.33% |
|
|
Return on Tangible Equity |
-31.09% |
-22.00% |
|
-28.33% |
|
$1.50 |
|
$-2.92 |
|
$-2.92 |
|